Literature DB >> 31109456

Role of iron metabolism in heart failure: From iron deficiency to iron overload.

Hao Zhang1, Pavel Zhabyeyev1, Shaohua Wang2, Gavin Y Oudit3.   

Abstract

Iron metabolism is a balancing act, and biological systems have evolved exquisite regulatory mechanisms to maintain iron homeostasis. Iron metabolism disorders are widespread health problems on a global scale and range from iron deficiency to iron-overload. Both types of iron disorders are linked to heart failure. Iron play a fundamental role in mitochondrial function and various enzyme functions and iron deficiency has a particular negative impact on mitochondria function. Given the high-energy demand of the heart, iron deficiency has a particularly negative impact on heart function and exacerbates heart failure. Iron-overload can result from excessive gut absorption of iron or frequent use of blood transfusions and is typically seen in patients with congenital anemias, sickle cell anemia and beta-thalassemia major, or in patients with primary hemochromatosis. This review provides an overview of normal iron metabolism, mechanisms underlying development of iron disorders in relation to heart failure, including iron-overload cardiomyopathy, and clinical perspective on the treatment options for iron metabolism disorders.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; Genetic regulation; Heart failure; Hemochromatosis; Hepcidin; Iron deficiency; Iron metabolism; Iron overload; Mitochondrial function

Mesh:

Substances:

Year:  2018        PMID: 31109456     DOI: 10.1016/j.bbadis.2018.08.030

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  15 in total

Review 1.  Iron deficiency as therapeutic target in heart failure: a translational approach.

Authors:  Constantinos Bakogiannis; Alexandros Briasoulis; Dimitrios Mouselimis; Anastasios Tsarouchas; Nikolaos Papageorgiou; Christodoulos Papadopoulos; Nikolaos Fragakis; Vassilios Vassilikos
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

Review 2.  Nanoparticle Effects on Stress Response Pathways and Nanoparticle-Protein Interactions.

Authors:  Shana J Cameron; Jessica Sheng; Farah Hosseinian; William G Willmore
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

3.  Myocardial Iron Deficiency and Mitochondrial Dysfunction in Advanced Heart Failure in Humans.

Authors:  Hao Zhang; K Lockhart Jamieson; Justin Grenier; Anish Nikhanj; Zeyu Tang; Faqi Wang; Shaohua Wang; Jonathan G Seidman; Christine E Seidman; Richard Thompson; John M Seubert; Gavin Y Oudit
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

4.  Heart Failure Hospitalization Risk associated with Iron Status in Veterans with CKD.

Authors:  Monique E Cho; Jared L Hansen; Brian C Sauer; Alfred K Cheung; Adhish Agarwal; Tom Greene
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237

5.  Iron Overload Induces Apoptosis and Cytoprotective Autophagy Regulated by ROS Generation in Mc3t3-E1 Cells.

Authors:  Guanpeng Xu; Xi Li; Zhiyong Zhu; Huisheng Wang; Xizhuang Bai
Journal:  Biol Trace Elem Res       Date:  2021-01-06       Impact factor: 3.738

6.  Oral Supplementation with Sucrosomial Ferric Pyrophosphate Plus L-Ascorbic Acid to Ameliorate the Martial Status: A Randomized Controlled Trial.

Authors:  Matteo Briguglio; Silvana Hrelia; Marco Malaguti; Elena De Vecchi; Giovanni Lombardi; Giuseppe Banfi; Patrizia Riso; Marisa Porrini; Sergio Romagnoli; Fabio Pino; Tiziano Crespi; Paolo Perazzo
Journal:  Nutrients       Date:  2020-01-31       Impact factor: 5.717

7.  Analytical evaluation of serum non-transferrin-bound iron and its relationships with oxidative stress and cardiac load in the general population.

Authors:  Tomonori Sugiura; Yasuaki Dohi; Hiroyuki Takase; Satoshi Fujii; Yoshihiro Seo; Nobuyuki Ohte
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

Review 8.  Ferroptosis Is a Potential Novel Diagnostic and Therapeutic Target for Patients With Cardiomyopathy.

Authors:  Zhenyu Zhai; Pengtao Zou; Fuxiang Liu; Zirong Xia; Juxiang Li
Journal:  Front Cell Dev Biol       Date:  2021-04-01

9.  Heart involvement in transfusion-dependent beta-thalassemia with conventional echocardiography.

Authors:  Hossein Esfahani; Asadolah Tanasan; Mina Rezanejad; Saadat Torabian
Journal:  Caspian J Intern Med       Date:  2021-04

Review 10.  The Human Explanted Heart Program: A translational bridge for cardiovascular medicine.

Authors:  Hao Zhang; Anissa Viveiros; Anish Nikhanj; Quynh Nguyen; Kaiming Wang; Wei Wang; Darren H Freed; John C Mullen; Roderick MacArthur; Daniel H Kim; Wayne Tymchak; Consolato M Sergi; Zamaneh Kassiri; Shaohua Wang; Gavin Y Oudit
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-10-22       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.